ANAVEX LIFE SCIENCES CORP. Increase (Decrease) in Accounts Payable and Accrued Liabilities
ANAVEX LIFE SCIENCES CORP. (AVXL) reported Increase (Decrease) in Accounts Payable and Accrued Liabilities of $451.98 thousand for the 9-month period ending 2019-06-30, per its 10-Q filed 2019-08-07.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities · last filed 2019-08-07
- ANAVEX LIFE SCIENCES CORP. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2019-06-30 was -$2.03M.
- ANAVEX LIFE SCIENCES CORP. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2019-03-31 was $1.49M, a 141.76% increase year-over-year.
- ANAVEX LIFE SCIENCES CORP. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2018-12-31 was $991.27K.
- ANAVEX LIFE SCIENCES CORP. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2018-09-30 was $675.56K, a 68.56% decline year-over-year.
- ANAVEX LIFE SCIENCES CORP. increase (decrease) in accounts payable and accrued liabilities for fiscal 2018 was $300.29K, a 45.86% decline from fiscal 2017.
- ANAVEX LIFE SCIENCES CORP. increase (decrease) in accounts payable and accrued liabilities for fiscal 2017 was $554.71K, a 28.46% decline from fiscal 2016.
- ANAVEX LIFE SCIENCES CORP. increase (decrease) in accounts payable and accrued liabilities for fiscal 2016 was $775.33K, a 40.84% decline from fiscal 2015.
- ANAVEX LIFE SCIENCES CORP. increase (decrease) in accounts payable and accrued liabilities for fiscal 2015 was $1.31M.
| Period end | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 89 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 92 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 95 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 98 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 101 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 104 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 107 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 110 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 113 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 116 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 119 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 122 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2019-06-30 | -$2.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-08-07 | -$539.29K derived: sum of 2 quarters · filed 2019-08-07 | $451.98K 10-Q · filed 2019-08-07 | $1.13M derived: sum of 4 quarters · filed 2019-08-07 | ||||||||||||
| 2019-03-31 | $1.49M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-05-09 | $2.49M 10-Q · filed 2019-05-09 | $3.16M derived: sum of 3 quarters · filed 2019-05-09 | $2.95M derived: sum of 4 quarters · filed 2019-08-07 | ||||||||||||
| 2018-12-31 | $991.27K 10-Q · filed 2019-02-07 | $1.67M derived: sum of 2 quarters · filed 2019-02-07 | $1.46M derived: sum of 3 quarters · filed 2019-08-07 | $2.08M derived: sum of 4 quarters · filed 2019-08-07 | ||||||||||||
| 2018-09-30 | $675.56K derived: 10-K 12 month − 10-Q 9 month · filed 2019-01-25 | $467.89K derived: sum of 2 quarters · filed 2019-08-07 | $1.09M derived: sum of 3 quarters · filed 2019-08-07 | $300.29K 10-K · filed 2019-01-25 | ||||||||||||
| 2018-06-30 | -$207.67K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-08-07 | $410.60K derived: sum of 2 quarters · filed 2019-08-07 | -$375.26K 10-Q · filed 2019-08-07 | $1.77M derived: sum of 4 quarters · filed 2019-08-07 | ||||||||||||
| 2018-03-31 | $618.26K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-05-09 | -$167.60K 10-Q · filed 2019-05-09 | $1.98M derived: sum of 3 quarters · filed 2019-05-09 | $1.47M derived: sum of 4 quarters · filed 2019-05-09 | ||||||||||||
| 2017-12-31 | -$785.86K 10-Q · filed 2019-02-07 | $1.36M derived: sum of 2 quarters · filed 2019-02-07 | $855.15K derived: sum of 3 quarters · filed 2019-02-07 | $725.38K derived: sum of 4 quarters · filed 2019-02-07 | ||||||||||||
| 2017-09-30 | $2.15M derived: 10-K 12 month − 10-Q 9 month · filed 2019-01-25 | $1.64M derived: sum of 2 quarters · filed 2019-01-25 | $1.51M derived: sum of 3 quarters · filed 2019-01-25 | $554.71K 10-K · filed 2019-01-25 | ||||||||||||
| 2017-06-30 | -$507.83K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-08-09 | -$637.60K derived: sum of 2 quarters · filed 2018-08-09 | -$1.59M 10-Q · filed 2018-08-09 | -$524.00K derived: sum of 4 quarters · filed 2019-01-25 | ||||||||||||
| 2017-03-31 | -$129.77K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-05-10 | -$1.09M 10-Q · filed 2018-05-10 | -$16.18K derived: sum of 3 quarters · filed 2019-01-25 | -$296.78K derived: sum of 4 quarters · filed 2019-01-25 | ||||||||||||
| 2016-12-31 | -$956.53K 10-Q · filed 2018-02-07 | $113.60K derived: sum of 2 quarters · filed 2019-01-25 | -$167.01K derived: sum of 3 quarters · filed 2019-01-25 | -$94.90K derived: sum of 4 quarters · filed 2019-01-25 | ||||||||||||
| 2016-09-30 | $1.07M derived: 10-K 12 month − 10-Q 9 month · filed 2019-01-25 | $789.52K derived: sum of 2 quarters · filed 2019-01-25 | $861.63K derived: sum of 3 quarters · filed 2019-01-25 | $775.33K 10-K · filed 2019-01-25 | ||||||||||||
| 2016-06-30 | -$280.61K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-08-07 | -$208.50K derived: sum of 2 quarters · filed 2017-08-07 | -$294.79K 10-Q · filed 2017-08-07 | $949.88K derived: sum of 4 quarters · filed 2017-12-11 | ||||||||||||
| 2016-03-31 | $72.11K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-05-10 | -$14.19K 10-Q · filed 2017-05-10 | $1.23M derived: sum of 3 quarters · filed 2017-12-11 | $1.07M derived: sum of 4 quarters · filed 2017-12-11 | ||||||||||||
| 2015-12-31 | -$86.30K 10-Q · filed 2017-02-07 | $1.16M derived: sum of 2 quarters · filed 2017-12-11 | $998.32K derived: sum of 3 quarters · filed 2017-12-11 | $1.12M derived: sum of 4 quarters · filed 2017-12-11 | ||||||||||||
| 2015-09-30 | $1.24M derived: 10-K 12 month − 10-Q 9 month · filed 2017-12-11 | $1.08M derived: sum of 2 quarters · filed 2017-12-11 | $1.21M derived: sum of 3 quarters · filed 2017-12-11 | $1.31M 10-K · filed 2017-12-11 | ||||||||||||
| 2015-06-30 | -$160.06K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-08-11 | -$35.74K derived: sum of 2 quarters · filed 2016-08-11 | $65.93K 10-Q · filed 2016-08-11 | -$250.10K derived: sum of 4 quarters · filed 2016-12-14 | ||||||||||||
| 2015-03-31 | $124.32K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-05-11 | $225.99K 10-Q · filed 2016-05-11 | -$90.05K derived: sum of 3 quarters · filed 2016-12-14 | -$54.54K derived: sum of 4 quarters · filed 2016-12-14 | ||||||||||||
| 2014-12-31 | $101.67K 10-Q · filed 2016-02-08 | -$214.36K derived: sum of 2 quarters · filed 2016-12-14 | -$178.85K derived: sum of 3 quarters · filed 2016-12-14 | -$121.48K derived: sum of 4 quarters · filed 2016-12-14 | ||||||||||||
| 2014-09-30 | -$316.03K derived: 10-K 12 month − 10-Q 9 month · filed 2016-12-14 | -$280.52K derived: sum of 2 quarters · filed 2016-12-14 | -$223.15K derived: sum of 3 quarters · filed 2016-12-14 | -$303.02K 10-K · filed 2016-12-14 | ||||||||||||
| 2014-06-30 | $35.51K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-08-14 | $92.89K derived: sum of 2 quarters · filed 2015-08-14 | $13.01K 10-Q · filed 2015-08-14 | $54.96K derived: sum of 4 quarters · filed 2015-08-14 | ||||||||||||
| 2014-03-31 | $57.38K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-05-14 | -$22.49K 10-Q · filed 2015-05-14 | $19.45K derived: sum of 3 quarters · filed 2015-05-14 | $142.88K derived: sum of 4 quarters · filed 2015-05-14 | $6.22M 10-Q/A · filed 2014-05-30 | |||||||||||
| 2013-12-31 | -$79.87K 10-Q · filed 2015-02-17 | -$37.93K derived: sum of 2 quarters · filed 2015-02-17 | $85.50K derived: sum of 3 quarters · filed 2015-02-17 | $65.78K derived: sum of 4 quarters · filed 2015-02-17 | $6.16M 10-Q · filed 2014-02-14 | |||||||||||
| 2013-09-30 | $41.94K derived: 10-K 12 month − 10-Q 9 month · filed 2014-12-29 | $165.37K derived: sum of 2 quarters · filed 2014-12-29 | $145.65K derived: sum of 3 quarters · filed 2014-12-29 | $465.91K 10-K · filed 2014-12-29 | $6.24M 10-K · filed 2013-12-30 | |||||||||||
| 2013-06-30 | $123.43K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2014-08-13 | $103.70K derived: sum of 2 quarters · filed 2014-08-13 | $423.97K 10-Q · filed 2014-08-13 | $847.26K derived: sum of 4 quarters · filed 2014-08-13 | $6.20M 10-Q · filed 2013-08-14 | |||||||||||
| 2013-03-31 | -$19.72K derived: 10-Q/A 6 month − 10-Q 3 month · filed 2014-05-30 | $300.54K 10-Q/A · filed 2014-05-30 | $723.84K derived: sum of 3 quarters · filed 2014-05-30 | $1.07M derived: sum of 4 quarters · filed 2014-05-30 | $6.07M 10-Q · filed 2013-05-17 | |||||||||||
| 2012-12-31 | $320.26K 10-Q · filed 2014-02-14 | $743.56K derived: sum of 2 quarters · filed 2014-02-14 | $1.09M derived: sum of 3 quarters · filed 2014-02-14 | $1.61M derived: sum of 4 quarters · filed 2014-02-14 | $6.09M 10-Q · filed 2013-02-14 | |||||||||||
| 2012-09-30 | $423.30K derived: 10-K 12 month − 10-Q 9 month · filed 2013-12-30 | $772.33K derived: sum of 2 quarters · filed 2013-12-30 | $1.29M derived: sum of 3 quarters · filed 2013-12-30 | $2.28M 10-K · filed 2013-12-30 | $5.77M 10-K · filed 2012-12-31 | |||||||||||
| 2012-06-30 | $349.03K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-08-14 | $870.48K derived: sum of 2 quarters · filed 2013-08-14 | $1.86M 10-Q · filed 2013-08-14 | $1.88M derived: sum of 4 quarters · filed 2013-08-14 | $5.35M 10-Q · filed 2012-08-17 | |||||||||||
| 2012-03-31 | $521.45K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-05-17 | $1.51M 10-Q · filed 2013-05-17 | $1.53M derived: sum of 3 quarters · filed 2013-05-17 | $1.82M derived: sum of 4 quarters · filed 2013-05-17 | $5.00M 10-Q · filed 2012-05-15 | |||||||||||
| 2011-12-31 | $987.27K 10-Q · filed 2013-02-14 | $1.01M derived: sum of 2 quarters · filed 2013-02-14 | $1.29M derived: sum of 3 quarters · filed 2013-02-14 | $2.01M derived: sum of 4 quarters · filed 2013-02-14 | $4.48M 10-Q · filed 2012-02-14 | |||||||||||
| 2011-09-30 | $17.74K derived: 10-K 12 month − 10-Q 9 month · filed 2012-12-31 | $307.44K derived: sum of 2 quarters · filed 2012-12-31 | $1.02M derived: sum of 3 quarters · filed 2012-12-31 | $1.13M 10-K · filed 2012-12-31 | $3.49M 10-K · filed 2011-12-22 | |||||||||||
| 2011-06-30 | $289.70K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-08-17 | $1.00M derived: sum of 2 quarters · filed 2012-08-17 | $1.11M 10-Q · filed 2012-08-17 | $1.40M derived: sum of 4 quarters · filed 2012-08-17 | $3.47M 10-Q · filed 2011-08-12 | |||||||||||
| 2011-03-31 | $710.65K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-05-15 | $821.86K 10-Q · filed 2012-05-15 | $1.11M derived: sum of 3 quarters · filed 2012-05-15 | |||||||||||||
| 2010-12-31 | $111.20K 10-Q · filed 2012-02-14 | $404.29K derived: sum of 2 quarters · filed 2012-02-14 | ||||||||||||||
| 2010-09-30 | $293.09K derived: 10-K 12 month − 10-Q 9 month · filed 2011-12-22 | $511.84K 10-K · filed 2011-12-22 | ||||||||||||||
| 2010-06-30 | $218.76K 10-Q · filed 2011-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |